 |
5,7-dichloro-2-dimethylaminomethyl-8-hydroxyquinoline hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Huntington disease |
| USA Market Approval | USA |
| USA Designation Date | 2014-09-04 00:00:00 |
| Sponsor | Prana Biotechnology Limited;Level 2, 369 Royal Parade, Parkville;Victoria 3052 |
Related Access Program